WE.SPEED.
12 patients with Ulcerative Colitis in a Phase 2a exploratory trial have been screened in the last three weeks. The first one was dosed today.
Across all ARENSIA studies in Kyiv, all patients’ visits happen per schedule, same for samples arriving - all on time at the Western European labs. IMP delivery happens without disruptions. All couriers, local labs, and imaging providers are fully functional.
ARENSIA team in Kyiv never stopped, never left, and continues to be at the top of their game.
The last few weeks were just ordinary weeks at ARENSIA Kyiv, with excellent results from a unique team!